Use of non-insulin therapies for type 1 diabetes

Diabetes Technol Ther. 2013 Nov;15(11):901-8. doi: 10.1089/dia.2013.0281. Epub 2013 Oct 16.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Allylamine / analogs & derivatives
  • Allylamine / therapeutic use
  • Animals
  • Blood Glucose / drug effects
  • Bromocriptine / therapeutic use
  • Cardiovascular Diseases / prevention & control
  • Colesevelam Hydrochloride
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetic Angiopathies / prevention & control
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Gastrins / agonists
  • Glucagon-Like Peptide 1 / analogs & derivatives
  • Glucagon-Like Peptide 1 / therapeutic use
  • Glycated Hemoglobin / drug effects
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemia / prevention & control
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Islet Amyloid Polypeptide / agonists
  • Islet Amyloid Polypeptide / therapeutic use
  • Leptin / analogs & derivatives
  • Leptin / therapeutic use
  • Metformin / therapeutic use
  • Sodium-Glucose Transporter 1 / antagonists & inhibitors
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / therapeutic use
  • United States / epidemiology

Substances

  • Blood Glucose
  • Dipeptidyl-Peptidase IV Inhibitors
  • Gastrins
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Islet Amyloid Polypeptide
  • Leptin
  • SLC5A1 protein, human
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 1
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • hemoglobin A1c protein, human
  • Bromocriptine
  • Allylamine
  • Glucagon-Like Peptide 1
  • Metformin
  • Colesevelam Hydrochloride
  • metreleptin